Thermo Fisher Scientific (TMO) Restructuring Costs (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Restructuring Costs for 18 consecutive years, with $49.0 million the latest figure, recorded in Q1 2026.

• Restructuring Costs for Q1 2026 came in at $49.0 million, down 50.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $312.0 million (down 30.36% YoY), and the FY2025 annual result was $70.0 million, up 40.0% from the prior year.
• Restructuring Costs was $49.0 million for Q1 2026 at Thermo Fisher Scientific, up from $46.0 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $228.0 million in Q4 2024 and troughed at $2.0 million in Q2 2022.
• Average Restructuring Costs over 5 years is $80.1 million, with a median of $77.0 million recorded in 2024.
• Year-over-year, Restructuring Costs tumbled 85.71% in 2022 and surged 5500.0% in 2023.
• Over 5 years, Restructuring Costs stood at $55.0 million in 2022, then jumped by 45.45% to $80.0 million in 2023, then jumped by 185.0% to $228.0 million in 2024, then slumped by 79.82% to $46.0 million in 2025, then grew by 6.52% to $49.0 million in 2026.
• Per Business Quant data, the three most recent Restructuring Costs figures were $49.0 million in Q1 2026, $46.0 million in Q4 2025, and $135.0 million in Q3 2025.